Global Reagents Markets Project Strong Growth Through 2033
Biotech reagents market projected to hit $148.21B by 2030; life science reagents to reach $114.4B by 2033. Growth driven by precision diagnostics, genomics, and personalized medicine.
Thermo Fisher Scientific Inc.
CompanyAlso known as: Thermo Fisher Scientific
Company Profile
Thermo Fisher Scientific is a global leader in serving science, helping customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity. Its products and services support biopharma, healthcare, academic, and government customers worldwide.
- Website
- https://www.thermofisher.com
- Headquarters
- Waltham, Massachusetts, USA
- Founded
- 2006
- Stock Ticker
- NYSE:TMO
Related News
Thermo Fisher Raises Guidance; Danaher's Recovery Uneven in Mixed Results
Thermo Fisher posted 10% revenue growth in Q2 and raised guidance; Danaher's Q1 revenue missed but EPS beat. Danaher cited bioprocessing and life sciences strength and expects growth to accelerate.
Revvity Raises Outlook After Strong Q2, Launches New Drug Discovery Platforms
Revvity beat Q2 expectations, raised its full-year outlook, and launched new drug discovery platforms at SLAS2026. Revenue totaled $711 million with 3% organic growth.
Pharmaceutical Equipment Markets Projected to See Strong Growth Through 2035
Flow chemistry, laboratory mixer, and industrial extruder markets are projected to grow significantly through 2035, driven by pharmaceutical continuous manufacturing, high R&D funding, and sustainability trends. Flow chemistry is expected to reach $12 billion, while laboratory mixers could hit $29.6 billion. Key players include Merck KGaA, BASF, and Lonza.
Japan's Regenerative Cell Therapy Push Advances With Regulatory Review, Market Growth, and New Patents
Japan's health ministry panel is reviewing two regenerative cell therapies for Parkinson's disease and heart failure, testing the country's push to build a domestic cell-based treatment industry. Japan's cell culture market is projected to reach USD 2.34 billion by 2031, driven by government support and favorable regulatory pathways. Australian firm Cartherics secured a Japanese patent for its iPSC-based immune cell therapies.
Fill-Finish Manufacturing to Hit $21B by 2030; Ampoule and Medical Membrane Markets Grow
New market reports project strong growth in pharmaceutical manufacturing: fill-finish is set to reach $21.04 billion by 2030, ampoule filling/sealing machines to grow at a 5.8% CAGR through 2035, and medical membranes to hit $6.6 billion by 2030.
Cell and Gene Therapy Reports Highlight Market Growth and Industry Tracking
Research and Markets added two cell and gene therapy publications, including a tools and reagents market report forecasting growth from $12 billion in 2025 to $19.8 billion by 2030. The reports track approvals, financing, deals, and manufacturing developments.
Omics Markets Projected Strong Growth Across Clinical Trials, Digital PCR Consumables, and Fluidic Samplers
Market reports project growth in omics-based clinical trials, Asia digital PCR consumables, and multi-omic fluidic samplers. The clinical trials market is set to reach $47.78B by 2030; fluidic samplers grow to $2.76B by 2036.
mRNA Synthesis and Manufacturing Market Seen Reaching $2.96 Billion by 2029
The mRNA synthesis and manufacturing market is projected to grow from USD 2.23 billion in 2024 to USD 2.96 billion by 2029 at a 5.8% CAGR. Consumables led in 2023, while Asia Pacific is expected to be the fastest-growing region.
Thermo Fisher joins PRECISE SG100K biobank initiative in Singapore
Thermo Fisher Scientific entered a collaboration with Singapore's PRECISE to support the PRECISE SG100K biobank initiative. The company will supply proteomics capabilities for precision medicine research and biomarker discovery in Asia Pacific.